Search results for "ISOTOPES"

showing 10 items of 1216 documents

18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.

2009

Abstract Introduction The serotonergic system, especially the 5-HT2A receptor, is involved in various diseases and conditions. It is a very interesting target for medicinal applications. Methods Two novel 5-HT2A tracers, namely, [ 18 F]DD-1 and the enantiomeric pure ( R )-[ 18 F]MH.MZ, were radiolabeled by 18 F-fluoroalkylation of the corresponding desmethyl analogue. In vitro binding autoradiography on rat brain slices was performed to test the affinity and selectivity of these tracers. Moreover, first μPET experiments of ( R )-[ 18 F]MH.MZ were carried out in Sprague-Dawley rats. Results [ 18 F]DD-1 ( K i =3.23 nM) and ( R )-[ 18 F]MH.MZ ( K i =0.72 nM) were 18 F-fluoroalkylated by the se…

MaleCancer ResearchFluorine RadioisotopesStereochemistryRats Sprague-DawleyPiperidinesAnimalsRadiology Nuclear Medicine and imagingReceptor Serotonin 5-HT2ARadioactive TracersRadiochemistryChemistrySynthonBinding potentialDesmethylCortex (botany)Molecular ImagingRatsFluorobenzenesPositron-Emission TomographySerotonin 5-HT2 Receptor AntagonistsMolecular MedicineAutoradiographySpecific activitySteady state (chemistry)EnantiomerSelectivityNuclear medicine and biology
researchProduct

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

2008

Abstract Purpose: We recently reported that anionic phospholipids, principally phosphatidylserine, become exposed on the external surface of vascular endothelial cells in tumors, probably in response to oxidative stresses present in the tumor microenvironment. In the present study, we tested the hypothesis that a chimeric monoclonal antibody that binds phosphatidylserine could be labeled with radioactive arsenic isotopes and used for molecular imaging of solid tumors in rats. Experimental Design: Bavituximab was labeled with 74As (β+, T1/2 17.8 days) or 77As (β−, T1/2 1.6 days) using a novel procedure. The radionuclides of arsenic were selected because their long half-lives are consistent w…

MaleCancer ResearchPathologymedicine.medical_specialtyBiodistributionBavituximabmedicine.drug_classPhosphatidylserinesMonoclonal antibodyArticleArsenicchemistry.chemical_compoundIn vivomedicineTumor Cells CulturedAnimalsTissue DistributionPlatelet activationRadioisotopesTumor microenvironmentbiologyNeovascularization PathologicAntibodies MonoclonalProstatic NeoplasmsPhosphatidylserineMolecular biologyXenograft Model Antitumor AssaysRatsOncologychemistryRadioimmunodetectionPositron-Emission Tomographybiology.proteinEndothelium VascularAntibodymedicine.drugClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection.

2010

Abstract Introduction 67 Ga citrate has been extensively used to detect infection and inflammation since 1971. However, its clinical utility is compromised due to several limitations. The present project explored whether 68 Ga- apo -transferrin ( 68 Ga-TF), when prepared in vitro, is a useful agent for positron emission tomography (PET) imaging of bacterial infection. Methods An infection was induced in male Wistar rats by injecting 5×10 5 CFU units of Staphyococcus aureus in the right thigh muscle. 68 Ga-TF was synthesized by mixing 68 GaCl 3 with apo -transferrin (TF, 2 mg) in sodium carbonate (0.1 M, pH 7.0) and incubating at 40°C for 1 h. Animals were injected with 10–15 MBq of 68 Ga-TF…

MaleCancer ResearchPathologymedicine.medical_specialtyBiodistributionStaphylococcus aureusMicrococcaceaeInflammationGalliumGallium RadioisotopesPharmacologyStaphylococcal infectionsmedicine.disease_causeLesionmedicineAnimalsRadiology Nuclear Medicine and imagingRats WistarProteus mirabilischemistry.chemical_classificationbiologybusiness.industryTransferrinStaphylococcal Infectionsbiology.organism_classificationmedicine.diseaseIn vitroRatschemistryStaphylococcus aureusTransferrinPositron-Emission TomographyMolecular Medicinemedicine.symptombusinessApoproteinsProteus InfectionsNuclear medicine and biology
researchProduct

Quantitative changes of metabolic and bioenergetic parameters in experimental tumors during fractionated irradiation.

1999

Abstract Purpose: Previous studies with rat rhabdomyosarcomas indicate that during fractionated irradiation profound alterations of the tumor microvasculature and the oxygenation status occur when the total dose exceeds 45 Gy. At this dose a destruction which included all structures of the vessels and a significant worsening in tumor oxygenation were found. The aim of the present study was to analyze whether these effects of fractionated irradiation on the microvasculature and on tumor oxygenation also induce changes in the bioenergetic and metabolic status in the tumors during radiation treatment. Methods and Materials: R1H rhabdomyosarcomas of the rat implanted into the flank were irradia…

MaleCancer ResearchPathologymedicine.medical_specialtyRadiobiologyTime Factorsmedicine.medical_treatmentAdenosine TriphosphateRhabdomyosarcomaMedicineAnimalsRadiology Nuclear Medicine and imagingIrradiationLactic AcidCobalt RadioisotopesRhabdomyosarcomaRadiationbusiness.industryDose fractionationRadiobiologyOxygenationTumor Oxygenationmedicine.diseaseRatsRadiation therapyGlucoseOncologySarcomaDose Fractionation RadiationNuclear medicinebusinessNeoplasm TransplantationInternational journal of radiation oncology, biology, physics
researchProduct

Development of a [177Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy

2015

Painful bone lesions, both benign and metastatic, are often managed using conventional analgesics. However, the treatment response is not immediate and is often associated with side-effects. Radionuclide therapy is used for pain palliation in bone metastases as well as some benign neoplasms. Endoradiotherapy has direct impact on the pain-producing bone elements, and hence, response is significant, with minimal or no side-effects. A new potential compound for endoradiotherapy is [(177)Lu]BPAMD. It combines a highly affine bisphosphonate, covalently bridged with DOTA through an amide bond, with the low-energy β(-) emitting therapeutic radiolanthanide (177)Lu. For routine chemical application,…

MaleCancer ResearchTreatment responsePathologymedicine.medical_specialtymedicine.medical_treatmentPainBone NeoplasmsLutetiumBone and BonesPain palliationchemistry.chemical_compoundmedicineHumansDOTARadiology Nuclear Medicine and imagingBenign neoplasmsAgedRadioisotopesPharmacologyDiphosphonatesStaining and Labelingbusiness.industryGeneral MedicineBisphosphonateAmidesOncologychemistryBone lesionRadionuclide therapyReagent Kits DiagnosticRadiopharmaceuticalsNuclear medicinebusinessCancer Biotherapy and Radiopharmaceuticals
researchProduct

Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.

2003

Outcome of patients with metastatic disease mainly depends on accurate preoperative tumor staging. 18[F]fluorodeoxyglucose positron emission tomography (18F-PET) has been proven to be a valuable diagnostic tool in a number of different tumors but its direct influence on liver surgery has not been thoroughly investigated. Between July 1999 and March 2000, 50 consecutive patients with 174 suspected liver lesions were admitted to the University Hospital Jena. All 50 patients underwent abdominal ultrasound, CT-scan, and 18-FDG positron emission tomography scanning. In 23 patients the diagnostic work-up was completed by MRI scan. Altogether there were a total of 174 histologically proven intrahe…

MaleCancer Researchmedicine.medical_specialtyFluorine RadioisotopesLiver tumorCarcinoma HepatocellularBreast NeoplasmsSensitivity and SpecificityResectionAdenoma Liver CellFluorodeoxyglucose positron emission tomographyFluorodeoxyglucose F18Internal medicinemedicineHumansMri scanNeoplasm StagingHematologymedicine.diagnostic_testbusiness.industryUltrasoundLiver NeoplasmsGeneral Medicinemedicine.diseaseUniversity hospitalOncologyPositron emission tomographyFemaleRadiologyRadiopharmaceuticalsbusinessNuclear medicineColorectal NeoplasmsFollow-Up StudiesTomography Emission-ComputedJournal of cancer research and clinical oncology
researchProduct

A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting

2016

Radiolabeled bisphosphonates are commonly used in the diagnosis and therapy of bone metastases. Blood clearance of bisphosphonates is usually fast and only 30%-50% of the injected activity is retained in the skeleton, while most of the activity is excreted by the urinary tract. A longer blood circulation may enhance accumulation of bisphosphonate compounds in bone metastases. Therefore, a chemically modified macrocyclic bisphosphonate derivative with an additional human albumin binding entity was synthesized and pharmacokinetics of its complex was evaluated. The DOTA-bisphosphonate conjugate BPAMD was compared against the novel DOTAGA-derived albumin-binding bisphosphonate DOTAGA(428-d-Lys)…

MaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSerum albuminGallium RadioisotopesBone and Bones030218 nuclear medicine & medical imagingHeterocyclic Compounds 1-Ring03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIn vivoInternal medicinemedicineAnimalsHumansDOTATissue DistributionRadiology Nuclear Medicine and imagingRats WistarSerum AlbuminDiphosphonatesbiologyAlbuminDiphosphonatesBisphosphonateHuman serum albuminRatsDurapatiteEndocrinologychemistryPositron-Emission Tomography030220 oncology & carcinogenesisbiology.proteinMolecular MedicineAdsorptionEx vivomedicine.drugNuclear Medicine and Biology
researchProduct

68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter

2012

Abstract Purpose Bone metastases are a serious aggravation for patients suffering from cancer. Therefore, early recognition of bone metastases is of great interest for further treatment of patients. Bisphosphonates are widely used for scintigraphy of bone lesions with 99m Tc. Using the 68 Ge/ 68 Ga generator together with a macroyclic bisphosphonate a comparable PET-tracer comes into focus. Procedures The bisphosphonate DOTA-conjugated ligand BPAMD was labelled with 68 Ga. [ 68 Ga]BPAMD was evaluated in vitro concerning binding to hydroxyapatite and stability. The tracer's in vivo accumulation was determined on healthy rats and bone metastases bearing animals by μ-PET. Results BPAMD was lab…

MaleCancer Researchmedicine.medical_treatmentBone NeoplasmsElectronsGallium RadioisotopesScintigraphyHeterocyclic Compounds 1-RingIn vivoCell Line TumormedicineAnimalsRadiology Nuclear Medicine and imagingRadiochemistryDiphosphonatesmedicine.diagnostic_testbusiness.industryChemistryPositron emittersCancerPet imagingBisphosphonateLigand (biochemistry)medicine.diseaseRatsDurapatiteBone lesionPositron-Emission TomographyMolecular MedicineNuclear medicinebusinessNuclear Medicine and Biology
researchProduct

Radiolabelling and preliminary evaluation of 68Ga-tetrapyrrole derivatives as potential tracers for PET

2013

article i nfo Tetrapyrroles are multisided natural products which are of relevance in clinical medicine. Owing to their specific accumulation in tumour tissue, porphyrins, metalloporphyrins and chlorins have been used as in photodynamic therapy and optical imaging. Moreover, their specific uptake into inflammatory atheromatous plaques via LDL endocytosis has been reported. The present study is concerned with the synthesis of 68 Ga labelled porphyrin derivatives and an in vitro assessment of the utility of radiotracers in positron emission tomography. A set of five porphyrin derivatives were labelled using 68 Ga from a commercially obtained radionuclide generator. Dedicated post-processing o…

MaleCancer Researchmedicine.medical_treatmentGallium RadioisotopesPhotodynamic therapyEndocytosischemistry.chemical_compoundDrug StabilityRadioligandmedicineAnimalsHumansRadiology Nuclear Medicine and imagingRadiochemistrymedicine.diagnostic_testRadiochemistryBlood ProteinsPorphyrinTetrapyrroleIn vitroRatsTetrapyrroleschemistryBiochemistryPositron emission tomographyIsotope LabelingPositron-Emission TomographyMolecular MedicineRadionuclide GeneratorNuclear Medicine and Biology
researchProduct

Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.

2015

Adolescence is characterized by drastic behavioral adaptations and comprises a particularly vulnerable period for the emergence of various psychiatric disorders. Growing evidence reveals that the pathophysiology of these disorders might derive from aberrations of normal neurodevelopmental changes in the adolescent brain. Understanding the molecular underpinnings of adolescent behavior is therefore critical for understanding the origin of psychopathology, but the molecular mechanisms that trigger adolescent behavior are unknown. Here, we hypothesize that the cannabinoid type-1 receptor (CB1R) may play a critical role in mediating adolescent behavior because enhanced endocannabinoid (eCB) sig…

MaleCannabinoid receptorAdolescentmedicine.medical_treatmentIn Vitro TechniquesImpulsivityMediatorRisk-TakingCocaineReceptor Cannabinoid CB1Sulfur IsotopesmedicineAnimalsHumansMaze LearningRadionuclide ImagingSocial BehaviorCannabinoid Receptor AntagonistsBehavior AnimalGeneral NeuroscienceNovelty seekingAge FactorsBrainArticlesPhenotypeEndocannabinoid systemCorpus StriatumRats Inbred F344RatsAdolescent BehaviorGuanosine 5'-O-(3-Thiotriphosphate)Models AnimalMutationExploratory BehaviorCannabinoid receptor antagonistCannabinoidmedicine.symptomRats TransgenicPsychologyNeuroscienceEndocannabinoidsThe Journal of neuroscience : the official journal of the Society for Neuroscience
researchProduct